Allogene Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 120.4M |
| FY2021 | 135.8M |
| FY2022 | 143.1M |
| FY2023 | 156.9M |
| FY2024 | 194.8M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 120.4M |
| FY2021 | 135.8M |
| FY2022 | 143.1M |
| FY2023 | 156.9M |
| FY2024 | 194.8M |